Media Summary: Dr Velamehr presents data at AACR about the production of chimeric antigen recombinant ( John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ... Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having "
Off The Shelf Car T - Detailed Analysis & Overview
Dr Velamehr presents data at AACR about the production of chimeric antigen recombinant ( John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ... Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having " While CAR T-cells are shaking-up the treatment paradigm, Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, reflects on allogeneic and Carlos Almeida Ramos, MD, PhD, Baylor College of Medicine, Houston, TX, discusses the benefits of CD30-targeting ...
Jae Park, MD, a hematologist oncologist at Memorial Sloan Kettering Cancer Center, discusses the benefits of Find out what drove John McKearn, Ph.D. & CEO at Wugen, out of the lab at Pfizer and on to his quest to develop Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, shares an update on the latest developments regarding ... Dr. Jain, Assistant Member, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, ... Prof. Maria Themeli tells about most recent developments in the field of “ Dr. Locke, Program Co-Leader, Immunology, Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee ...
Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of Dr. Goy, Chairman, John Theurer Cancer Center, Part of Hackensack University Medical Center, considers whether Jürgen Kuball, MD, PhD, Utrecht University, Utrecht, Netherlands, gives an update on Catherine Bollard, MBChB, MD, FRACP, FRCPA, Children's National Health System, Washington, DC, outlines studies exploring ... Dr. Neelapu, Professor, Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD ...
